,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, diarrhea, vomiting, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, hypertension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension"
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction with fatal outcome, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, Posterior reversible encephalopathy syndrome, Embryo-fetal Toxicity, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, cardiac arrest, renal impairment, renal failure, pneumonitis, interstitial lung disease, pulmonary arterial hypertension, deep venous thrombosis, pulmonary embolism, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, increased serum transaminases, seizure, headache, lethargy, confusion, blindness, altered consciousness"
2,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, dyspeptic signs and symptoms, asthenic conditions, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, Photosensitivity reaction, dysgeusia, early increases in creatinine >=10%, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease including pneumonitis and pulmonary fibrosis, Anaphylactic reactions including angioedema, Vasculitis, including leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, hospitalization for heart failure"
4,MULTAQ,warnings and precautions,"cardiovascular death, heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, QT interval prolongation, stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, marked increase in serum creatinine, pre-renal azotemia, acute renal failure"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
7,TEFLARO,warnings and precautions,"Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), Direct Coombs' test seroconversion, serious skin reactions, mild diarrhea, fatal colitis, increased morbidity and mortality, drug-induced hemolytic anemia, development of drug-resistant bacteria"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"Hypersensitivity reactions, skin erythema, pruritis, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase, elevated total bilirubin"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, worsening of transaminase elevations, development of transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, Cutaneous squamous cell carcinoma, Keratoacanthoma, Melanoma, Basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, Recurrent NRAS mutation-positive colorectal carcinoma, Head and neck carcinoma, Glioblastoma, Intracranial hemorrhage, Gastric hemorrhage, Deep venous thrombosis, Pulmonary embolism, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Hypotension, Rigors or chills, Dehydration, Renal failure, Secondary infections of the skin"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"driving impairment, somnolence/sedation, dizziness, suicidal thoughts or behaviors, somnolence, fatigue/asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, tumors, breast tumors, brain tumors, lung tumors, adrenal tumor, non-Hodgkin's lymphoma, endometrial carcinoma in situ, tumor worsening"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, stomatitis, dyspepsia, urinary tract infection, skin infections, sinusitis, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, gastroesophageal reflux disease, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock (fatal), urticaria, angioedema"
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, progressive multifocal leukoencephalopathy (PML), neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, palpitations, lightheadedness, dyspnea, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, fetal harm, malformations, reduced fetal weights"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions"
19,ULORIC,warnings and precautions,"gout flares, cardiovascular thromboembolic events, myocardial infarctions, strokes, hepatic failure, fatal hepatic failure, non-fatal hepatic failure, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Back pain, Pharyngitis, Acute bronchitis, Fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, lupus-like syndrome, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
21,CIMZIA,boxed warnings,"Active tuberculosis, reactivation of latent tuberculosis, disseminated tuberculosis, extrapulmonary tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, disseminated fungal infections, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella infections, Listeria infections, serious infections leading to hospitalization, death, tuberculosis (TB), bacterial sepsis, lymphoma, malignancies, fatal malignancies"
22,CIMZIA,warnings and precautions,"Serious infections, Invasive fungal infections, lymphoma, other malignancies, Heart failure, Anaphylaxis, serious allergic reactions, Hepatitis B virus reactivation, Demyelinating disease, Cytopenias, pancytopenia, Lupus-like syndrome, Opportunistic infections, Tuberculosis, Hepatosplenic T-cell lymphoma (HSTCL), acute and chronic leukemia, worsening congestive heart failure (CHF), new onset CHF, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, Neurologic reactions, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, bacteria in sputum, arthralgia, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
24,KALYDECO,warnings and precautions,"Elevated transaminases, increased transaminase levels, non-congenital lens opacities/cataracts"
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
26,FULYZAQ,warnings and precautions,if infectious etiologies are not considered and the patient is incorrectly treated with FULYZAQ for non-infectious diarrhea
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, procedural pain, increases in blood pressure"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome, anaphylaxis, hypotension, hypoalbuminemia, edema, hemoconcentration, Tumor Growth Stimulatory Effects on Malignant Cells"
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, Aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions, bullous eruption"
32,COARTEM,warnings and precautions,"prolongation of the QT interval, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, hypokalemia, hypomagnesemia, decreased exposure to lumefantrine, decreased efficacy, decreased concentrations of the substrate, potential loss of substrate efficacy, increased concentrations of artemether and/or lumefantrine, potentiate QT prolongation, decreased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, reduce the effectiveness of hormonal contraceptives, increase plasma concentrations of the coadministered drug, increase the risk of adverse effects, risk of recrudescence, relapsing malaria"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, ear and labyrinth disorders, eye disorders, visual impairment, gastrointestinal disorders, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, nervous system disorders, balance disorder, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, vascular disorders, hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal thoughts or behavior, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Dizziness, Disturbance in gait and coordination, Somnolence, Fatigue, Cognitive dysfunction, Visual changes, Increased seizure frequency, Status epilepticus, Drug Induced Liver Injury, Abnormal thyroid function tests"
35,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Bone pain, Myalgia, Spinal osteoarthritis, Sciatica, Insomnia, Rash, Pruritus, New Malignancies, cataracts, Drug-related hypersensitivity reactions: anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe cases of musculoskeletal pain, Marked elevation in serum PTH"
36,PROLIA,warnings and precautions,"hypersensitivity including anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections including skin infections, dermatitis, rashes, eczema, severe bone, joint, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, marked elevations of serum parathyroid hormone (PTH), serious skin infections, infections of the abdomen, urinary tract, ear infections, endocarditis"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), life-threatening, fatal, Neurological toxicities, severe"
39,BLINCYTO,warnings and precautions,"Cytokine Release Syndrome (CRS), life-threatening or fatal CRS, infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, febrile neutropenia, loss of consciousness, transient elevations in liver enzymes, Grade 3 or greater elevations in liver enzymes, leukoencephalopathy, preparation and administration errors"
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION)"
41,STENDRA,warnings and precautions,"hypotension, erection lasts greater than 4 hours, sudden loss of vision, sudden decrease or loss of hearing, priapism, painful erections greater than 6 hours in duration, penile tissue damage, permanent loss of potency, decreased vision, dizziness, lightheadedness, fainting, headache"
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, flexor tendon rupture, pruritus, tenderness, injection site swelling, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
43,XIAFLEX,boxed warnings,"corporal rupture (penile fracture), penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, possible permanent injury, tendon rupture, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, flexor tendon ruptures, damage to collagen-containing structures, permanent injury, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), skin laceration requiring skin graft, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, mild allergic reactions (pruritus), severe allergic reactions, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis"
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, exacerbate clinical effects, corneal exposure, corneal ulceration, reduced blinking, corneal exposure with possible ulceration or perforation, diplopia, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, swallowing difficulties, breathing difficulties, severe dysphagia, aspiration, critical loss of breathing capacity, respiratory failure, severe dysphagia, respiratory compromise, persistent epithelial defect, corneal ulceration, ectropion, narrow angle glaucoma, Ecchymosis"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, serious adverse reactions, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, Gastrointestinal disorders, Stomatitis, Cheilitis, Skin and subcutaneous tissue disorders, Infections and infestations, Cystitis, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Epistaxis, Rhinorrhea, Investigations, Weight Decreased, General disorders and administration site conditions, Pyrexia, Eye disorders, Conjunctivitis, Laboratory Abnormalities, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis"
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, Bullous disorders, Exfoliative Skin Disorders, blistering lesions, exfoliating lesions, Interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, Hepatic toxicity, Fatal hepatic impairment, liver test abnormalities, Keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, Embryofetal toxicity, fetal harm, embryotoxic, abortions"
50,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis, Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, Pyrexia, Nausea, Vomiting, Fatigue, Diarrhea, Constipation, Anorexia, Cough, Headache, Weight decreased, Dyspnea, Rash, Stomatitis, Lymphopenia, Anemia, Leukopenia, Thrombocytopenia, Neutropenia, Asthenia, Malaise, Weakness, Dry mouth, Somnolence, Mucosal inflammation, Worsening hypertension, Hypertensive crisis, Hypersensitivity, Nasopharyngitis, Infection, Herpes simplex, Hyperuricemia, Pruritus, Hemoglobin Decreased, Platelets Decreased, Leukocytes Decreased, Bilirubin elevations, Increased AST, Increased ALT, Creatinine levels changes, Tachycardia, Constipation, Stomatitis, Abdominal pain, Dyspepsia, Gastroesophageal reflux disease, Abdominal pain upper, Abdominal distension, Chills, Edema peripheral, Chest pain, Infusion site pain, Pain, Catheter site pain, Herpes zoster, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Pneumonia, Febrile neutropenia, Oral candidiasis, Weight decreased, Anorexia, Dehydration, Decreased appetite, Hypokalemia, Back pain, Arthralgia, Pain in extremity, Bone pain, Headache, Dizziness, Dysgeusia, Insomnia, Anxiety, Depression, Cough, Pharyngolaryngeal pain, Wheezing, Nasal congestion, Dry skin, Night sweats, Hyperhidrosis, Hypotension, Hemolysis, Dysgeusia/taste disorder, Atypical pneumonia, Sepsis, Herpes zoster, Erythema, Dermatitis, Skin necrosis, Anaphylaxis, Injection or infusion site reactions, Phlebitis, Irritation, Pain, Swelling, Pneumocystis jiroveci pneumonia, Pneumonitis, SJS, TEN"
51,TREANDA,warnings and precautions,"myelosuppression, death from myelosuppression, infections, fever, signs of infection, anaphylaxis, infusion reactions, severe anaphylactic reactions, tumor lysis syndrome, acute renal failure, death from acute renal failure, skin reactions, severe skin reactions, SJS, TEN, fatal SJS, fatal TEN, pre-malignant diseases, malignant diseases, extravasation, embryo-fetal toxicity, fetal harm, neutropenic sepsis, diffuse alveolar hemorrhage, Grade 3 thrombocytopenia, pneumonia from opportunistic infection, CMV, pneumonia, sepsis, septic shock, death from infections, pruritus, rash, anaphylactoid reactions, allergic-type reactions, rash, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, erythema, marked swelling, pain, redness, swelling, pain, infection, necrosis, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights"
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"Imaging errors, allergic reactions, anaphylaxis, increased risk for cancer"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis and hemorrhage, Systemic hypersensitivity, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Vomiting, Nausea, Hyperbilirubinemia, Abdominal pain/discomfort, Diarrhea, Allergy, Coagulopathy (hemorrhage, thrombosis or infarct), Hyperlipidemia, Ketoacidosis, CNS events (hemorrhage, thrombosis or infarction, and cerebral venous thrombosis), Hepatobiliary disorders"
55,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe pancreatitis, hemorrhagic pancreatitis, Glucose intolerance, hyperglycemia, Thrombosis, hemorrhage, Grade 3 hypersensitivity reactions, Grade 4 hypersensitivity reactions, abdominal pain, amylase elevation, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, Dyspepsia, Fatigue, Gastrointestinal Adverse Reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, Documented symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, sinus tachycardia, Immunogenicity, Systemic hypersensitivity adverse reactions, Injection-site reactions, PR Interval Prolongation, First Degree Atrioventricular (AV) Block, Amylase and Lipase Increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors (adenomas and carcinomas), medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"Thyroid C-cell tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease"
59,ADREVIEW,adverse reactions,"Serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, serious reactions in premature or low birth-weight infants, increased radiation exposure, decreased quality of AdreView images, iodine 123 accumulation in the thyroid, false negative imaging results, clinically significant withdrawal symptoms, toxicity (hypotension, metabolic acidosis), increased incidence of kernicterus, deaths in preterm infants, decreased cardiac uptake of AdreView, increased long term risk for thyroid neoplasia, transient episode of hypertension"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle, and internal organs"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactoid/anaphylactic reactions with cardiovascular manifestations, Anaphylactoid/anaphylactic reactions with respiratory manifestations, Anaphylactoid/anaphylactic reactions with cutaneous manifestations, Death from hypersensitivity reactions, Fatal or debilitating fibrosis affecting the skin, Fatal or debilitating fibrosis affecting the muscle, Fatal or debilitating fibrosis affecting internal organs, Acute kidney injury requiring dialysis, Tissue irritation from extravasation"
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleeds, subdural bleeds, gastrointestinal bleeds, hypersensitivity, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, clinical myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment"
66,PRADAXA,warnings and precautions,"serious and fatal bleeding, thrombotic events, blood loss, hypotension, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions"
67,ELIQUIS,adverse reactions,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Syncope, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Epistaxis, Gastrointestinal hemorrhage, Hematochezia, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Hematuria, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Muscle hemorrhage, Ocular hemorrhage, Rectal hemorrhage, Menorrhagia, Hemorrhagic anemia, Hemorrhoidal hemorrhage, Traumatic hematoma, Periorbital hematoma, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis"
69,ELIQUIS,warnings and precautions,"serious, potentially fatal bleeding, increased risk of thrombotic events, stroke, bleeding, risk of bleeding, signs and symptoms of blood loss, active pathological hemorrhage, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, numbness or weakness of the legs, bowel or bladder dysfunction"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis"
71,ZERBAXA,warnings and precautions,"Decreased efficacy in patients with baseline CrCl of 30 to <=50 mL/min, Serious hypersensitivity (anaphylactic) reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, serious infections, death, neutropenia, infection"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, embryofetal death, malformations, increased ALT values, increased serum ALT levels, increase in both ALT and AST, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma"
76,DALVANCE,warnings and precautions,"Serious hypersensitivity (anaphylactic) and skin reactions, reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, abnormalities in liver tests (ALT, AST, bilirubin), mild diarrhea to fatal colitis, increased morbidity and mortality"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, respiratory-related deaths, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
78,ARCAPTA,boxed warnings,asthma-related death
79,ARCAPTA,warnings and precautions,"clinically significant cardiovascular effects, fatalities, Immediate hypersensitivity reactions, Life-threatening paradoxical bronchospasm, increases in pulse rate, systolic or diastolic blood pressure, symptoms, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, significant hypokalemia, increases in plasma glucose"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"prolongation of the PR, QTc, and/or QRS cardiac intervals, cardiac arrhythmias"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle, and internal organs"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, hypersensitivity reactions with cardiovascular manifestations, hypersensitivity reactions with respiratory manifestations, hypersensitivity reactions with cutaneous manifestations, death from hypersensitivity reactions, acute kidney injury requiring dialysis, moderate irritation from extravasation, overestimation of the extent of malignant disease in MRI of the breast"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, elevations in alanine aminotransferase (ALT), jaundice, elevations in aspartate aminotransferase (AST), total bilirubin, severe life-threatening or fatal ILD/pneumonitis, pneumonitis, CTCAE Grade 3 or 4 ILD/pneumonitis, fatal ILD/pneumonitis, ventricular tachyarrhythmias, Torsade de pointes, sudden death, QTc interval increase, sinus bradycardia, symptomatic bradycardia, life-threatening bradycardia, CTCAE Grade 3-4 hyperglycemia, CTCAE Grade 3-4 elevations of lipase and/or amylase, skeletal anomalies"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, Electrocardiogram QT prolonged, Vision disorder, Vomiting, Diarrhea, Constipation, Dyspepsia, Dysphagia, Abdominal pain, Pyrexia, Upper respiratory infection, Weight increased, Pain in extremity, Muscle spasm, Dizziness, Dysgeusia, Headache, nausea, fatigue, neuropathy, rash, renal cyst, ILD, syncope, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, acute respiratory distress syndrome, arrhythmia, dyspnea, pneumonitis, respiratory failure, sepsis, alanine aminotransferase (ALT) elevation, QTc prolongation, neutropenia, ILD, ALT and AST elevation, dyspnea, pulmonary embolism, Hypokalemia, hepatic failure"
88,XALKORI,warnings and precautions,"Fatal hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, Concurrent elevations in alanine aminotransferase (ALT) or aspartate aminotransferase (AST) greater than or equal to three times the upper limit of normal (ULN) and total bilirubin greater than or equal to two times the ULN, Elevations in ALT or AST greater than five times the ULN, Grade 3 or 4 ILD, Fatal ILD, QTcF (corrected QT by the Fridericia method) greater than or equal to 500 ms, Increase from baseline QTcF greater than or equal to 60 ms, Torsade de pointes, Polymorphic ventricular tachycardia, Signs/symptoms of serious arrhythmia, Heart rate less than 50 beats per minute, Grade 3 syncope, Embryotoxicity, Fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"Based on the provided structured product label excerpt, there are no explicit mentions of adverse drug reactions directly associated with the use of the drug itself. The text primarily focuses on warnings, precautions, and instructions for use to minimize risks such as contamination and improper use with contact lenses. Therefore, no adverse drug reactions can be extracted from this specific excerpt."
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, increases in serum creatinine, low hemoglobin, low hematocrit, low RBC counts, high and low markedly abnormal platelet counts, high and low markedly abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury to the developing fetus, death to the developing fetus"
93,EDARBI,warnings and precautions,"fetal renal function reduction, fetal and neonatal morbidity increase, fetal and neonatal death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Influenza, Weight increased, Paresthesia, Amnesia, Dysphasia, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
95,POTIGA,boxed warnings,"retinal abnormalities, vision loss, damage to the photoreceptors, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, vision loss, funduscopic abnormalities, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, catheterization, hydronephrosis, renal function impairment, urinary hesitation, dysuria, psychosis, withdrawal seizures"
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema (including swelling of the lips, tongue, or throat), urticaria, rash, bronchospasm, itching"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, urticaria, rash, itching"
99,PROMACTA,adverse reactions,"Hepatic Decompensation in Patients with Chronic Hepatitis C, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, headache, hyperbilirubinemia, cataract, fatigue, serum liver test abnormalities, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, hyperbilirubinemia, total bilirubin greater than or equal to 1.5 x ULN, ALT or AST greater than or equal to 3 x ULN, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, cytogenetic abnormalities, Thrombotic microangiopathy with acute renal failure"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"ascites, encephalopathy, liver enzyme elevations, indirect hyperbilirubinemia, increased direct bilirubin, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, portal venous system events, venous and arterial events, thrombotic complications, portal vein thrombosis (PVT), abdominal pain, nausea, vomiting, diarrhea, cataracts"
102,INLYTA,adverse reactions,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm, grade 3/4 hypertension, transient ischemic attack, cerebrovascular accident, myocardial infarction, retinal artery occlusion, pulmonary embolism, deep vein thrombosis, retinal vein occlusion, retinal vein thrombosis, cerebral hemorrhage, hematuria, hemoptysis, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, hyperthyroidism, wound healing complications"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbation of existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, Hyperpyrexia, confusion, exacerbate symptoms in patients with existing ischemic heart disease, exacerbate symptoms in patients with arrhythmias, exacerbate symptoms in patients with congestive heart failure, Allergic reactions, fever or hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, allergic-type reactions, bronchial asthma"
107,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst (including polydipsia), volume depletion (e.g., blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolemia, orthostatic hypotension, syncope), increased urination (e.g., polyuria, pollakiuria, nocturia), increases in serum creatinine, decreases in eGFR, hypoglycemia, genital mycotic infections (e.g., vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis), phimosis, urinary tract infections (e.g., urinary tract infection, asymptomatic bacteriuria, cystitis), increase in low-density lipoprotein cholesterol (LDL-C), increase in hematocrit"
108,JARDIANCE,warnings and precautions,"Hypotension, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Urinary tract infections, Increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular (e.g., heart failure, sudden death), infectious (e.g., pneumonia)"
111,FANAPT,warnings and precautions,"increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular/cerebrovascular risk, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, hyperpyrexia, muscle rigidity, altered mental status, catatonic signs, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, ketoacidosis, hyperosmolar coma, death, cholesterol alterations, LDL alterations, HDL alterations, triglycerides alterations, Hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, mammary gland proliferative changes, serum prolactin elevation, gynecomastia, galactorrhea, body temperature regulation disruption, Dysphagia, esophageal dysmotility, aspiration, aspiration pneumonia, somnolence, sedation"
112,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, increased gamma glutamyltransferase (GGT), heart rate increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, acute pancreatitis, persistent severe abdominal pain, vomiting, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, immunogenicity"
116,EYLEA,warnings and precautions,"Endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, arrhythmia, dyspepsia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, gastritis, intestinal obstruction"
118,JEVTANA,boxed warnings,"Neutropenic deaths, neutropenia, severe hypersensitivity, generalized rash/erythema, hypotension, bronchospasm"
119,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity reactions, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, renal failure, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, sepsis, septic shock, generalized rash/erythema, hypotension, bronchospasm, electrolyte imbalance, ileus, enterocolitis, abdominal pain, tenderness, fever, persistent constipation, obstructive uropathy"
120,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions including ocular manifestations, Fatigue, Diarrhea, Pruritus, Rash, Colitis, Diarrhea (32%, 5% Grade 3-5), Colitis (8%, 5% Grade 3-5), Pruritus (31%, 0% Grade 3-5), Rash (29%, 2% Grade 3-5), Fatigue (41%, 7% Grade 3-5), Enterocolitis (7%, including fatal outcome and intestinal perforation), Hepatotoxicity (1%, including fatal outcome), Dermatitis (2%, including fatal outcome), Neuropathy (1%, including fatal outcome), Endocrinopathy, Hypopituitarism, Adrenal insufficiency, Pneumonitis, Meningitis, Nephritis, Eosinophilia, Pericarditis (including fatal outcome and underlying etiology not established), Urticaria (2%), Large intestinal ulcer, Esophagitis, Acute respiratory distress syndrome, Renal failure, Infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)."
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
122,YERVOY,warnings and precautions,"severe and fatal immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe, life-threatening, or fatal immune-mediated enterocolitis, moderate enterocolitis, intestinal perforation, complications, hospitalized for severe enterocolitis, severe, life-threatening, or fatal hepatotoxicity, fatal hepatic failure, hospitalization, moderate hepatotoxicity, liver function test abnormalities, immune-mediated hepatitis, severe, life-threatening, or fatal immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic, bullous, or hemorrhagic manifestations, severe dermatitis, moderate dermatitis, fatal Guillain-Barre syndrome, severe (Grade 3) peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, severe to life-threatening immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, severe endocrinopathies, moderate endocrinopathy, hypothyroidism, adrenal insufficiency, hypopituitarism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, angioedema, urticaria, hypersensitivity, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, hyperphosphatemia"
124,FARXIGA,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
125,PICATO,adverse reactions,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, vesiculation/pustulation, erosion/ulceration, erythema, crusting, swelling, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Proteinuria, Orthostatic hypotension, Stevens-Johnson syndrome"
128,PRISTIQ,boxed warnings,suicidal thoughts and behaviors
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, activation of mania/hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, worsening of depression, emergence of suicidality, suicidal ideation, unusual changes in behavior, suicidal thinking, suicidal behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), increases in blood pressure, gastrointestinal bleeding, ecchymosis, hematoma, epistaxis, petechiae, life-threatening hemorrhages, dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances (e.g., paresthesia, such as electric shock sensations), confusion, lethargy, emotional lability, hypomania, tinnitus, headache, difficulty concentrating, memory impairment, confusion, weakness, unsteadiness, hallucination, syncope, seizure, coma, respiratory arrest, death, progressive dyspnea, cough, chest discomfort"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Urine RBC (Hematuria), Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, alkaline phosphatase elevation, bilirubin elevation, serum glucose abnormalities, glycosuria, neutrophils decrease, fasting cholesterol increase, fasting triglycerides increase, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
131,STRIBILD,boxed warnings,"Lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B"
132,STRIBILD,warnings and precautions,"acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, proximal renal tubular dysfunction, acute renal failure, bone pain, pain in extremities, fractures, muscular pain, weakness, decreases in bone mineral density, osteomalacia, arthralgias, muscle pain, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders (such as Graves' disease, polymyositis, Guillain-Barre syndrome)"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD) predominantly involving the central nervous system (CNS), increased susceptibility to infection, possible development of malignancies, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), increased risk of other malignancies, Progressive Multifocal Leukoencephalopathy (PML), increased risk of bacterial infections, increased risk of viral infections, increased risk of fungal infections, increased risk of protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy leading to kidney graft loss, graft loss, death, deteriorating renal function, increased rate and grade of acute rejection, Grade III rejection"
136,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
137,LUMIZYME,boxed warnings,"anaphylactic reactions, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac arrest, death, cardiac resuscitation, defibrillation, loss of motor function, ventilator dependence"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal or debilitating fibrosis affecting the skin, muscle, and internal organs"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, fatal or debilitating fibrosis affecting the skin, muscle and internal organs, acute kidney injury, drug-induced kidney toxicity, NSF, hypersensitivity reactions, anaphylactic reactions, acute kidney injury requiring dialysis, local tissue reactions, myocyte necrosis, inflammation, falsely high or low serum iron values, reduced hepatic contrast, elevated serum ferritin levels, reduced hepatic contrast due to high serum bilirubin"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation"
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, fetal harm, teratogenicity, embryo-fetal lethality"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"birth defects, fetal death, anemia, decrease in hemoglobin concentrations, worsening of neutropenia, serious acute hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, neutropenia, severe or life-threatening infections, life-threatening neutropenia, pancytopenia"
146,VIMIZIM,adverse reactions,"Anaphylaxis and hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue"
147,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, serious acute exacerbation of respiratory compromise, hypersensitivity reactions"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression, back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased"
150,SIRTURO,boxed warnings,"increased mortality, QT prolongation, significant ventricular arrhythmia"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, increased risk of death, Clinically significant ventricular arrhythmia, A QTcF interval of greater than 500 ms, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations accompanied by total bilirubin elevation greater than two times the upper limit of normal, aminotransferase elevations greater than eight times the upper limit of normal, aminotransferase elevations greater than five times the upper limit of normal and persist beyond two weeks"
152,NEURACEQ,adverse reactions,"erythema (1.7 %), irritation (1.2 %), pain (3.9 %)"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, errors in Neuraceq estimation of brain neuritic beta-amyloid plaque density, errors leading to image interpretation, errors due to severe brain atrophy, errors due to motion artifacts, increased risk of cancer"
154,COMETRIQ,adverse reactions,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, general deterioration, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), vomiting, dysphagia, dyspepsia, hemorrhoids, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia"
155,COMETRIQ,boxed warnings,"Gastrointestinal perforations, fistula formation, severe hemorrhage, sometimes fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, serious arterial thromboembolic events, dehiscence, complications requiring medical intervention, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), fetal harm, Gastrointestinal (GI) perforations, fistulas, fatal GI fistula, Non-GI fistulas including tracheal/esophageal, fatal Non-GI fistulas, symptoms of perforations and fistulas, Serious hemorrhage, fatal hemorrhage, Grade >=3 hemorrhagic events, recent history of hemorrhage or hemoptysis, thrombotic events, venous thromboembolism, arterial thromboembolism, acute myocardial infarction, clinically significant arterial thromboembolic complication, Wound complications, wound healing complications, treatment-emergent hypertension, severe hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, Proteinuria, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hyperglycemia, Dyspnea, Pneumonitis, Hypercholesterolemia, Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Lymphopenia, Hyperglycemia, Anemia, Decreased potassium, Increased aspartate transaminase (AST), Increased ALT, Thrombocytopenia, Acute renal failure, Acute respiratory distress, Cardiac arrest, Death (cause unknown), Hepatic failure, Pneumonia, Sepsis, Pulmonary embolism, Hypoglycemia, Myocardial infarction with congestive heart failure, Sudden death, Renal failure, Thrombotic events, Pulmonary embolus, Thrombosis, Vomiting, Constipation, Dry mouth, Edema peripheral, Pyrexia, Asthenia, Weight decreased, Hyperglycemia, Arthralgia, Back pain, Pain in extremity, Dysgeusia, Insomnia, Epistaxis, Pruritus, Alopecia, Hot flush, Hemoglobin decreased, WBC decreased, Platelets decreased, Lymphocytes decreased, Neutrophils decreased, Glucose increased, Cholesterol increased, Aspartate transaminase (AST) increased, Alanine transaminase (ALT) increased, Triglycerides increased, Albumin decreased, Potassium decreased, Creatinine increased, Alkaline phosphatase increased, Bicarbonate decreased, Phosphate decreased, Calcium decreased, Sodium decreased, Bilirubin increased, Potassium increased, Dehydration, Abdominal pain, Dyspnea, Fatigue, Stomatitis, Asthenia, Anemia, Hypercholesterolemia, Hypertriglyceridemia, Hyperglycemia, Lymphopenia, Increased creatinine, Hypophosphatemia, Hypercholesterolemia, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Epistaxis, Decreased appetite, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Pneumonitis, Angioedema, Pyrexia, Pneumonia, Gastroenteritis, Aggression, Agitation, Amenorrhea, Elevated partial thromboplastin time, Neutropenia, Hypercholesterolemia, Elevated aspartate transaminase (AST), Hypertriglyceridemia, Elevated alanine transaminase (ALT), Hypophosphatemia, Cellulitis, Hyperglycemia, Elevated creatinine, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy"
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, fatal renal failure, impaired wound healing, wound-related complications, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, avoid live vaccines, embryo-fetal toxicity, fetal harm, hypoxia, pleural effusion, cough, dyspnea, pneumocystis jiroveci pneumonia (PJP), radiological changes, moderate symptoms, Grade 3 non-infectious pneumonitis, Grade 4 non-infectious pneumonitis, bacterial infections, fungal infections, viral infections, protozoal infections, opportunistic pathogens, pneumonia, mycobacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia, viral infections, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, swelling of the airways or tongue, respiratory impairment, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, surgical intervention, deaths, permanent treatment discontinuation, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets"
159,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, Candida albicans infection of the mouth and pharynx, increased risk of pneumonia, worsening of infections, existing tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, more serious or fatal course of chickenpox, more serious or fatal course of measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,laryngeal attacks
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), hypersensitivity-related adverse reactions (including erythema, rash, pruritus, urticaria, and angioedema), photosensitivity-related adverse reactions (including photosensitivity reaction, polymorphic light eruption, and sunburn), volume depletion-related adverse reactions (e.g., hypotension, postural dizziness, orthostatic hypotension, syncope, and dehydration), falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, phimosis, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in Low-Density Lipoprotein Cholesterol (LDL-C) and non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)."
165,INVOKANA,warnings and precautions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, including anaphylactic reactions"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"acute pancreatitis, anaphylaxis, angioedema, severe cutaneous adverse reactions, hepatic failure, hypoglycemia, severe and disabling arthralgia, Stevens-Johnson syndrome, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure increase, hypotension, dizziness, fatigue, palpitations, chest pain, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, hypertension"
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
173,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation, Severe neutropenia, Grade 4 neutropenia, Febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, Neuropathy lasting more than one year, New or worsening neuropathy, Embryo-fetal toxicity, Teratogenicity"
174,INTELENCE,adverse reactions,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis"
175,INTELENCE,warnings and precautions,"Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors (especially false negatives), Radiation risk, increased risk of cancer"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin irritation, scalp irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, erythema, rash, skin exfoliation, pruritus, pyoderma"
179,ULESFIA,warnings and precautions,"gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, decrease appetite, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, loss of efficacy, depression or depressed mood, suicidal ideation and behavior, suicidal behavior, weight decrease between 5%-10% of body weight, weight decrease of >=10% of body weight"
182,ILARIS,adverse reactions,"infections predominantly of the upper respiratory tract, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, intra-abdominal abscess following appendectomy, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, decreased white blood cells, decreased neutrophils, decreased platelets, elevations of transaminases, high ALT and/or AST, mild elevations of serum bilirubin"
183,ILARIS,warnings and precautions,"increased risk of serious infections, infections, recurring infections, underlying conditions predisposing to infections, active infection requiring medical intervention, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, unusual or opportunistic infections, new tuberculosis, reactivation of latent tuberculosis, malignancies, hypersensitivity reactions, macrophage activation syndrome"
184,NATAZIA,adverse reactions,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, Headaches, Menstrual disorders, Nausea/or vomiting, Acne, Mood changes, Increased weight, Menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), Mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), Headache (including migraines), Weight increased, Breast pain, discomfort or tenderness, Menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage), Nausea or vomiting, Acne, Mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying), Increased weight, Myocardial infarction, Ruptured ovarian cyst, Deep vein thrombosis, Focal nodular hyperplasia of the liver, Uterine leiomyoma, Acute cholecystitis, Chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), Hypertension, Gallbladder disease, Hepatitis, Hypersensitivity, Fluid retention, Hypertriglyceridemia, Dizziness, Chloasma, Angioedema, Erythema nodosum, Erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, jaundice, high blood pressure, significant change in headaches, irregular bleeding, amenorrhea, decreased contraceptive efficacy, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, loss of vision, proptosis, diplopia, papilledema, retinal vascular lesions, retinal vein thrombosis, cervical cancer, intraepithelial neoplasia, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, blood pressure rises significantly, gallbladder disease, decreased glucose tolerance, adverse lipid changes, hypertriglyceridemia, pancreatitis, new headaches, recurrent headaches, persistent headaches, severe headaches, migraine, breakthrough bleeding, spotting, intracyclic bleeding, depression, interference with laboratory tests, hereditary angioedema, chloasma"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions (dyspnea, angioedema, rash, pruritus)"
188,DIFICID,warnings and precautions,"angioedema, dyspnea, pruritus, rash"
189,ONFI,adverse reactions,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, constipation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, Vomiting, Constipation, Dysphagia, Pyrexia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Somnolence, Sedation, Lethargy, Drooling, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, Aspiration, respiratory depression, Rash, urticaria, angioedema, facial and lip edema"
190,ONFI,warnings and precautions,"Somnolence, Sedation, Withdrawal symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical and Psychological Dependence, Suicidal Behavior and Ideation, Convulsions, Psychosis, Hallucinations, Behavioral disorder, Tremor, Anxiety, Dysphoria, Insomnia"
191,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, elevations of hepatic transaminases, transient increase in mean eosinophil counts"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, progressive multifocal leukoencephalopathy (PML), death, severe disability, prolonged lymphopenia, progressive weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory and orientation leading to confusion, personality changes, decrease in lymphocyte counts, infections, serious infections, flushing, warmth, redness, itching, burning sensation"
193,DYSPORT,adverse reactions,"muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, breathing difficulties, dyspnea, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness"
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, swallowing difficulties"
195,DYSPORT,warnings and precautions,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death related to spread of toxin effects, severe dysphagia, aspiration, critical loss of breathing capacity, respiratory failure, increased incidence of eyelid ptosis"
196,ZYTIGA,adverse reactions,"fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, hypokalemia, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis"
197,ZYTIGA,warnings and precautions,"hypertension, hypokalemia, fluid retention, increases in liver enzymes, drug interruption, dose modification, discontinuation, grade 3 to 4 hypertension, grade 3 to 4 hypokalemia, grade 3 to 4 edema, adrenal insufficiency, grade 3 or 4 ALT or AST increases, treatment discontinuation due to liver enzyme increases, elevations of AST, ALT, bilirubin"
198,DUAVEE,adverse reactions,"muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, venous thromboembolism (deep venous thrombosis, pulmonary embolism, retinal vein thrombosis)"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), cancer of the uterus, heart disease, heart attacks, strokes, dementia, blood clots, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus, liver problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, exacerbation of hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, increased weight (repeated), akathisia (repeated), dizziness (repeated), extrapyramidal symptoms (repeated), somnolence (repeated), insomnia, hypertension, dyspepsia, toothache, arthralgia, pain in extremity, headache, anxiety, depression, tachycardia, glossodynia, irritability (repeated), muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, edema peripheral, dystonia, bradykinesia, dyskinesia, dystonia (repeated), oromandibular dystonia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, parkinsonism (repeated), protrusion tongue, resting tremor, tremor, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling/sloughing, inflammation, choking"
202,SAPHRIS,boxed warnings,Increased mortality in elderly patients with dementia-related psychosis
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, anaphylaxis, angioedema, dizziness, tachycardia, bradycardia, syncope, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive impairment, motor impairment, suicide, death, heart failure, sudden death, pneumonia, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, polydipsia, polyuria, polyphagia, weakness, ketoacidosis, hyperosmolar coma, hypotension, respiratory depression, central nervous system depression, fever, infection, torsade de pointes, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, somnolence, hypersomnia, body temperature regulation disruption, pyrexia, feeling hot, dysphagia, aspiration pneumonia"
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure (IOP) increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, cornea or sclera perforations, bacterial infections, secondary ocular infections, viral infections, exacerbation of viral infections severity, fungal infections, corneal ulceration"
206,ZYDELIG,adverse reactions,"Hepatotoxicity, Severe Diarrhea or Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, pyrexia, sepsis, febrile neutropenia, diarrhea, elevated transaminases, diarrhea or colitis, rash, nausea, vomiting, diarrhea, gastroesophageal reflux disease, stomatitis, headache, pyrexia, chills, pain, rash, pneumonia, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, ALT increased, AST increased, GGT increased, triglycerides (hypertriglyceridemia), hyperglycemia, hypoglycemia, hyponatremia, diarrhea, abdominal pain, vomiting, fatigue, pyrexia, asthenia, peripheral edema, upper respiratory tract infection, pneumonia, cough, dyspnea, rash, night sweats, headache, decreased appetite, insomnia, ALT increased, AST increased, neutrophils decreased, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, fatal and/or serious hepatotoxicity, elevations in ALT or AST, severe diarrhea or colitis, fatal and serious pneumonitis, fatal and serious intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, treatment-emergent Grade 3 or 4 neutropenia"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, local pruritus, erythema, pain, irritation, urticaria, bruising, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
210,KALBITOR,boxed warnings,Anaphylaxis
211,KALBITOR,warnings and precautions,"anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis"
213,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, neuropathic pain, weakness, anaphylaxis, infusion reactions, neutropenia, thrombocytopenia, anemia, febrile neutropenia, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, progressive multifocal leukoencephalopathy (PML), pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), fetal harm, embryo-fetal toxicities, fetal malformations, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"overgrowth of non-susceptible organisms including fungi, super-infection"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
219,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis resulting in death, fall-related injuries, hypertensive crisis"
220,XTANDI,warnings and precautions,seizure
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low), Absolute Neutrophil Count (Low), Hemoglobin (Low), SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low), Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity: diarrhea, nausea, vomiting, abdominal pain, Myelosuppression: thrombocytopenia, anemia, neutropenia, Hepatic Toxicity: drug induced liver injury, ALT elevation, AST elevation, Fluid Retention: pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, Renal Toxicity: decline in estimated glomerular filtration rate (eGFR), Embryofetal Toxicity: fetal harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage, acute symptomatic hyperammonemia"
225,SIMPONI,adverse reactions,"upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, serious infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, malignancy, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, administration reactions, immunogenicity, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections leading to hospitalization or death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, lymphoma, malignancies, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella infections, Listeria infections"
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, malignancies, lymphoma, other malignancies, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, worsening congestive heart failure, new onset congestive heart failure, new onset or exacerbation of central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, serious infections with abatacept, serious infections and neutropenia with anakinra, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, clinical infections from live vaccines, disseminated infections from live vaccines, clinical infections from therapeutic infectious agents, disseminated infections from therapeutic infectious agents"
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, mild infusion reactions of nausea, erythematous rash, pruritus, eyelid edema, headache, dyspnea, Fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"mortality, serious infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), neurological deficits, hypersensitivity reactions, anaphylaxis, death, depression, suicidality, worsening depression, suicidal thoughts, mood changes, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, infections leading to discontinuation of treatment, infections resulting in death, malignancies, non-melanoma skin cancers, rash, nausea, fatigue, myalgia, headache, facial edema, hypotension, angioedema, urticaria, pruritus, dyspnea, infusion reactions, bradycardia, skin reactions, insomnia, anxiety, serious psychiatric events, serious depression, suicides"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, diverticulitis, irritable bowel syndrome, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
231,TOVIAZ,warnings and precautions,"Angioedema of the face, lips, tongue, and/or larynx, urinary retention, severe constipation, headache, dizziness, somnolence"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,myocardial infarction
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction with flushing, dyspnea, chest pressure"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, radiation risk, increased risk of cancer"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, increased incidence of seizures, seizures at 20 mg twice daily, seizures during treatment with dalfampridine 15 mg twice daily, seizures during treatment with 10 mg twice daily, seizures in the post-marketing period, seizures in patients without a history of seizures, renal impairment, increased risk of seizures in patients with mild renal impairment, severe allergic reactions, respiratory compromise, urticaria, angioedema of the throat and or tongue, urinary tract infections"
239,ADCETRIS,all-concat,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity including pneumonitis, interstitial lung disease, ARDS, Toxic epidermal necrolysis"
240,ADREVIEW,all-concat,"Serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, hypersensitivity reactions, toxicity (hypotension, metabolic acidosis), Gasping Syndrome, increased radiation exposure, decreased quality of scintigraphic images, transient episode of hypertension"
241,AFINITOR,all-concat,"Non-infectious pneumonitis, Infections, Angioedema with concomitant use of ACE inhibitors, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hyperglycemia, Dyspnea, Hypercholesterolemia, Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Gastrointestinal disorders, General disorders and administration site conditions, Infections and infestations, Investigations, Metabolism and nutrition disorders, Musculoskeletal and connective tissue disorders, Nervous system disorders, Psychiatric disorders, Respiratory, thoracic and mediastinal disorders, Skin and subcutaneous tissue disorders, Vascular disorders, Hematology, Clinical chemistry, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy, Pneumocystis jiroveci pneumonia (PJP), Hepatitis B virus reactivation, Hyperlipidemia, Hypertriglyceridemia, Hyperglycemia, Decreased hemoglobin, Decreased lymphocytes, Decreased neutrophils, Decreased platelets, Elevated serum creatinine, Proteinuria, Hypophosphatemia, Increased creatinine, Amenorrhea, Menstrual irregularities, Vaginal hemorrhage, Epistaxis, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Pneumonitis, Angioedema, Cellulitis, Elevated creatinine, Hyperglycemia, Acute respiratory failure, Infection, Acute renal failure, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hand-foot syndrome, Nail disorder, Erythema, Onychoclasis, Skin lesion, Acneiform dermatitis, Exacerbation of pre-existing diabetes mellitus, New onset of diabetes mellitus, Insomnia, Dizziness, Paresthesia, Eyelid edema, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal failure, Tachycardia, Congestive cardiac failure, Jaw pain, Hemorrhage"
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions and Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, eye disorders, gastrointestinal disorders, general disorders and administration site conditions, infections and infestations, injury, poisoning and procedural complications, metabolism and nutrition disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, laryngeal edema, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, disturbance in gait and coordination, balance disorder, gait disturbance, nystagmus, abnormal coordination, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, impaired vision, visual impairment, diarrhea, constipation, abdominal pain, gastritis, urinary tract infections, fall, cough, rash, hypertension"
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, cough post-inhalation, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, febrile neutropenia, leukopenia (neutropenia and lymphopenia), serious and fatal infections (e.g., pneumonia and sepsis), hepatic toxicity and liver function test abnormalities, fetal harm, teratogenicity, embryo-fetal lethality"
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Progressive Multifocal Leukoencephalopathy (PML), upper respiratory tract infection, urinary tract infection, sinusitis, influenza, pneumonia, cellulitis, erythematous rash, pruritus, eyelid edema, headache, dyspnea, cardiovascular disease, suicide, JC virus-associated PML, neurological deficits, non-melanoma skin cancers, rash, fatigue, myalgia, facial edema, hypotension, angioedema, urticaria, bradycardia, skin reactions, psychiatric events, insomnia, anxiety, serious psychiatric events, serious depression, suicidal behavior"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm"
251,BOSULIF,all-concat,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval of greater than 500 milliseconds, Platelet Count (Low), Absolute Neutrophil Count (Low), Hemoglobin (Low), SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus (Low), Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption"
252,BREO,all-concat,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, hypokalemia, hyperglycemia"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, brain injury/damage, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, cardiac arrhythmias"
255,CHOLINE,all-concat,"mild injection site reaction, Imaging errors, allergic reactions, anaphylaxis, increased risk for cancer"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, Serious Infections, Malignancies, Heart Failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, Anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, Angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, Optic neuritis, retinal hemorrhage, uveitis, Bleeding, injection site reactions, Elevated liver enzymes, hepatitis, Alopecia totalis, Anxiety, bipolar disorder, suicide attempt, Nephrotic syndrome, renal failure, Menstrual disorder, Dermatitis, erythema nodosum, Thrombophlebitis, vasculitis, Headache, Hypertension, Nasopharyngitis, Back pain, Pharyngitis, Acute bronchitis, Fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, Active tuberculosis, Invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Bacterial, viral and other infections due to opportunistic pathogens, Legionella, Listeria, Hepatitis B virus reactivation, Demyelinating disease, Cytopenias, Lupus-like syndrome, angioedema, dermatitis allergic, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, (vasovagal) syncope"
257,CLEVIPREX,all-concat,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), QT prolongation"
259,COMETRIQ,all-concat,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, general deterioration, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), Gastrointestinal perforations, fistula formation, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, arterial thromboembolic events, dehiscence, complications requiring medical intervention, hypertensive crisis, nephrotic syndrome, embryofetal toxicity, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, persistent jaw pain, slow healing of the mouth or jaw after dental surgery, seizures, headache, visual disturbances, confusion, altered mental function, embryolethal, skeletal variations, visceral variations, malformations"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, serious hypersensitivity (anaphylactic) and skin reactions, reactions resembling ""Red-Man Syndrome"""
261,DATSCAN,all-concat,"hypersensitivity reactions, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema"
262,DIFICID,all-concat,"nausea (11%), vomiting (7%), abdominal pain (6%), gastrointestinal hemorrhage (4%), anemia (2%), neutropenia (2%), abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions (dyspnea, angioedema, rash, pruritus)"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
264,DUAVEE,all-concat,"muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), gallbladder disease, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, lupus, liver problems, breast cancer, ovarian cancer, hypertriglyceridemia, cholestatic jaundice, hypothyroidism, hypocalcemia, hereditary angioedema"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, blurred vision, diplopia, reduced visual acuity and accommodation, breathing difficulties, dyspnea, muscle atrophy, asthenia, generalized muscle weakness, ptosis, dysarthria, urinary incontinence, facial paresis, hypoesthesia, erythema, excessive granulation tissue, photophobia, influenza-like illness, amyotrophy, burning sensation, vertigo, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, fatigue, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, bronchitis, influenza, pharyngolaryngeal pain, contact dermatitis, injection site swelling, injection site bruising, injection site reaction (numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling), gait disturbance, hypertonia, sensation of heaviness"
267,EDARBI,all-concat,"diarrhea, hypotension/orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high and low markedly abnormal platelet counts, high and low markedly abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, injury and death to the developing fetus, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, neonatal hypotension, renal failure, neonatal death, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure"
268,ELIQUIS,all-concat,"Increased risk of thrombotic events after premature discontinuation, Bleeding, Spinal/epidural anesthesia or puncture, Intracranial bleed, Hemorrhagic stroke, Gastrointestinal (GI) bleed, Fatal bleeding, Intracranial, Non-intracranial, Hypersensitivity reactions, Syncope, Nausea, Anemia, Contusion, Hemorrhage, Postprocedural hemorrhage, Transaminases increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, Thrombocytopenia, Hypotension, Epistaxis, Gastrointestinal hemorrhage, Hematochezia, Liver function test abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Hematuria, Wound secretion, Incision-site hemorrhage, Operative hemorrhage, Gingival bleeding, Hemoptysis, Muscle hemorrhage, Ocular hemorrhage, Rectal hemorrhage, Hemorrhagic anemia, Hemorrhoidal hemorrhage, Hematemesis, Melena, Anal hemorrhage, Wound hemorrhage, Postprocedural hemorrhage, Traumatic hematoma, Periorbital hematoma, Vaginal hemorrhage, Metrorrhagia, Menometrorrhagia, Genital hemorrhage, Hemorrhage, Ecchymosis, Skin hemorrhage, Petechiae, Conjunctival hemorrhage, Retinal hemorrhage, Eye hemorrhage, Blood urine present, Occult blood positive, Occult blood, Red blood cells urine positive, Injection-site hematoma, Vessel puncture-site hematoma"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea and vomiting, diarrhea"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Blood pressure increased, Injection site reactions (pain, burning, coldness, extravasation, irritation), Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus (generalized, eye), Rash, Respiratory disorders (dyspnea, respiratory distress), Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Elevation of serum iron values, Serum bilirubin laboratory values increased, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness"
271,ERWINAZE,all-concat,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis and hemorrhage, Systemic hypersensitivity, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Vomiting, Nausea, Hyperbilirubinemia, Abdominal pain/discomfort, Diarrhea, Allergic reactions, Coagulopathy (hemorrhage, thrombosis or infarct), Hyperlipidemia, Ketoacidosis, CNS events (hemorrhage, thrombosis or infarction, and cerebral venous thrombosis), Anaphylaxis, Severe or hemorrhagic pancreatitis, Sagittal sinus thrombosis, Pulmonary embolism, Decreased coagulation proteins (fibrinogen, protein C activity, protein S activity, anti-thrombin III)"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, increased mortality in elderly patients with dementia-related psychosis, cerebrovascular adverse events including stroke, QT prolongation, arrhythmia, sudden death, neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, body temperature regulation disruption, dysphagia, suicide risk, priapism, cognitive and motor impairment"
274,FARXIGA,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, hyperphosphatemia"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
277,FULYZAQ,all-concat,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury"
279,GILENYA,all-concat,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Diarrhea, Abdominal pain, Asthenia, Back pain, Pain in extremity, Alopecia, Actinic keratosis, Liver transaminase elevations, Blood triglycerides increased, Cough, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma, symptomatic bradycardia, hypotension, fatigue, palpitations, chest pain, transient AV conduction delays, first-degree AV block, second-degree AV blocks, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, bronchitis, herpes zoster, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, herpes simplex infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, macular edema, dose-dependent reductions in forced expiratory volume, diffusion lung capacity for carbon monoxide, elevation of liver transaminases, jaundice, dark urine, fetal harm, increase in systolic pressure, increase in diastolic pressure, hypertension, decreased lymphocyte counts"
280,GILOTRIF,all-concat,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, serious adverse reactions, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, dehydration, renal failure, renal impairment, cutaneous reactions, rash, erythema, acneiform rash, palmar-plantar erythrodysesthesia syndrome, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, embryotoxic, abortions"
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus"
283,HORIZANT,all-concat,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, tumors (breast, brain, lung, adrenal, non-Hodgkin's lymphoma, endometrial carcinoma in situ), tumor worsening (brain, breast, prostate)"
284,ILARIS,all-concat,"infections predominantly of the upper respiratory tract, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, urinary tract infection, viral infection, rhinitis, intra-abdominal abscess following appendectomy, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, vertigo, hypersensitivity reactions, decreased white blood cells, neutrophils, platelets, high ALT and/or AST, mild elevations of serum bilirubin, tuberculosis, reactivation of latent tuberculosis, opportunistic infections, malignancies, anaphylactic reactions, macrophage activation syndrome"
285,IMBRUVICA,all-concat,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, creatinine increased, stomatitis, dyspepsia, urinary tract infection, skin infections, sinusitis, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, chills, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, progressive multifocal leukoencephalopathy (PML)"
286,INLYTA,all-concat,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia, hypertensive crisis, arterial thromboembolic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula formation, reversible posterior leukoencephalopathy syndrome (RPLS), elevation of liver enzymes, hepatic impairment, fetal harm"
287,INTELENCE,all-concat,"Severe skin and hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", autoimmune disorders (such as Graves' disease, polymyositis, Guillain-Barre syndrome)"
288,INVOKANA,all-concat,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (i.e., asthenia), pancreatitis (acute or chronic), erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, serum creatinine increase, estimated GFR fall, significant renal function decline, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, biochemical hypoglycemia, severe hypoglycemia, adjudicated bone fractures, increases in serum potassium, severe elevations in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C), increases in hemoglobin, decreases in Bone Mineral Density (BMD)."
289,JARDIANCE,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infections, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst (including polydipsia), volume depletion (e.g., blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolemia, orthostatic hypotension, syncope), increased urination (e.g., polyuria, pollakiuria, nocturia), increases in serum creatinine, decreases in eGFR, hypoglycemia, genital mycotic infections (e.g., vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis), phimosis, urinary tract infections (e.g., urinary tract infection, asymptomatic bacteriuria, cystitis), increase in Low-Density Lipoprotein Cholesterol (LDL-C), increase in Hematocrit"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, gastritis, intestinal obstruction, neutropenic deaths, generalized rash/erythema, bronchospasm, neutropenic infections, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, ileus, enterocolitis, increased AST, increased ALT, increased bilirubin"
291,JUBLIA,all-concat,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, local pruritus, erythema, pain, irritation, urticaria, bruising, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash"
293,KALYDECO,all-concat,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, bacteria in sputum, arthralgia, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, non-congenital lens opacities/cataracts"
294,KYPROLIS,all-concat,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity and Hepatic Failure, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, peripheral neuropathies NEC, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dizziness, epistaxis, hepatic failure, bronchitis, nasopharyngitis, respiratory tract infection, hyperglycemia, hypocalcemia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, embolic and thrombotic events, venous, rash"
295,LUMIZYME,all-concat,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema, peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
296,MULTAQ,all-concat,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia and hypomagnesemia with potassium-depleting diuretics, QT prolongation, Diarrhea, Nausea, Abdominal pain, Vomiting, Asthenia, Gastrointestinal disorders, Bradycardia, Including rashes (generalized, macular, maculo-papular, erythematous), Pruritus, Eczema, Dermatitis, Dermatitis allergic, Photosensitivity reaction, Dysgeusia, Early increases in creatinine >=10%, QTc prolonged, Atrial flutter with 1:1 atrioventricular conduction, Interstitial lung disease including pneumonitis and pulmonary fibrosis, Anaphylactic reactions including angioedema, Vasculitis, including leukocytoclastic vasculitis, Increased risk of death, Stroke, Hepatocellular liver injury, Acute liver failure requiring transplant, Marked increase in serum creatinine, Pre-renal azotemia, Acute renal failure"
297,NATAZIA,all-concat,"Serious cardiovascular events and stroke, Vascular events, Liver disease, Irregular uterine bleeding, Nausea, Breast tenderness, Headache, Headache (including migraines) 13%, Breast tenderness, pain 7%, Menstrual disorders 7%, Nausea/ or vomiting 6%, Acne 4%, Mood changes 3%, Increased weight 3%, Menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding) 2.3%, Mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying) 1.2%, Acne 1.1%, Headache (including migraines) 1.1%, Weight increased 0.7%, Headache (including migraines) (12.7%), Breast pain, discomfort or tenderness (7.0%), Menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage) 6.9%, Nausea or vomiting 6.0%, Acne 3.9%, Mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying) 3.0%, Increased weight 2.9%, Myocardial infarction, Ruptured ovarian cyst, Deep vein thrombosis, Focal nodular hyperplasia of the liver, Uterine leiomyoma, Acute cholecystitis, Chronic acalculous cholecystitis, Venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), Hypertension, Gallbladder disease, Hepatitis, Hypersensitivity, Fluid retention, Hypertriglyceridemia, Dizziness, Chloasma, Angioedema, Erythema nodosum, Erythema multiforme, Gastrointestinal symptoms (for example, abdominal pain), Vulvovaginal candidiasis"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"injection site reaction consisting of erythema (1.7 %), irritation (1.2 %), pain (3.9 %), Image interpretation errors (especially false positives), increased risk of cancer"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, falls, urinary tract infections, syncope, allergic reactions"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis with cryptococcal meningitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, urinary tract infection, upper respiratory infection, nasopharyngitis, influenza, bronchitis, constipation, abdominal pain, abdominal pain upper, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, cough, dyspnea, blood creatinine increased, arthralgia, back pain, headache, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, including aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, including acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
302,ONFI,all-concat,"constipation, somnolence or sedation, pyrexia, lethargy, drooling, lethargy, somnolence, ataxia, aggression, fatigue, insomnia, vomiting, constipation, dysphagia, pyrexia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence or sedation, somnolence, sedation, lethargy, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
304,PICATO,all-concat,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis"
305,POTIGA,all-concat,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, Somnolence, QT interval effect, Suicidal behavior and ideation, Withdrawal seizures, Fatigue, Confusional state, Vertigo, Tremor, Abnormal coordination, Diplopia, Disturbance in attention, Memory impairment, Asthenia, Blurred vision, Gait disturbance, Aphasia, Dysarthria, Balance disorder, Nausea, Constipation, Dyspepsia, Influenza, Weight increased, Paresthesia, Amnesia, Dysphasia, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, Increased appetite, Hallucinations, Myoclonus, Peripheral edema, Hypokinesia, Dry mouth, Dysphagia, Hyperhydrosis, Urinary retention, Malaise, Increased liver enzymes, Rash, Nystagmus, Dyspnea, Leukopenia, Muscle spasms, Alopecia, Nephrolithiasis, Syncope, Neutropenia, Thrombocytopenia, Euphoric mood, Renal colic, Coma, Encephalopathy"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleeds, subdural bleeds, gastrointestinal bleeds, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding in a critical area or organ, intraocular bleeding, intraspinal bleeding, intramuscular with compartment syndrome bleeding, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, angioedema, thrombocytopenia, esophageal ulcer, spinal/epidural hematoma, thromboembolic events, valve thrombosis, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, Stevens-Johnson syndrome"
308,PROLIA,all-concat,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, marked elevation in serum PTH, new malignancies"
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, headache, hyperbilirubinemia, cataract, serum liver test abnormalities, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, hyperbilirubinemia, total bilirubin greater than or equal to 1.5 x ULN, ALT or AST greater than or equal to 3 x ULN, pain in extremity, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, cytogenetic abnormality, Thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, indirect hyperbilirubinemia, liver test abnormalities"
310,QUTENZA,all-concat,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, coughing, sneezing"
311,SAPHRIS,all-concat,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, increased weight, increased appetite, akathisia, dizziness, extrapyramidal symptoms, somnolence, insomnia, hypertension, dry mouth, dyspepsia, toothache, fatigue, increased weight, increased appetite, arthralgia, pain in extremity, akathisia, dizziness, dysgeusia, headache, other extrapyramidal symptoms (excluding akathisia), somnolence, anxiety, depression, insomnia, tachycardia, oral paraesthesia, nausea, vomiting, abdominal pain, glossodynia, fatigue, irritability, muscle strain, increased weight, hyperinsulinemia, ALT increased, AST increased, increased appetite, dehydration, myalgia, somnolence, headache, dizziness, dysgeusia, akathisia, parkinsonism, insomnia, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, dystonia, parkinsonism, oculogyration, tremor, anaphylaxis, angioedema, hypotension, tachycardia, swollen tongue, dyspnea, wheezing, rash, orthostatic hypotension, syncope, leukopenia, neutropenia, agranulocytosis, QT prolongation, hyperprolactinemia, seizures, cognitive and motor impairment, body temperature regulation, suicide, dysphagia, aspiration pneumonia"
312,SIMPONI,all-concat,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, infusion reactions, immunogenicity, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, hepatitis B reactivation, heart failure, demyelinating disease, pancytopenia, aplastic anemia, thrombocytopenia"
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, Nausea, Arthralgia, Headache, Hemoptysis, Chest pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, Aminotransferase elevations, Clinically significant ventricular arrhythmia, QTcF interval of greater than 500 ms, Fatigue, Jaundice, Dark urine, Liver tenderness, Hepatomegaly"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION), priapism, sudden decrease or loss of hearing"
315,STRIBILD,all-concat,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Urine RBC (Hematuria), Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
316,TAFINLAR,all-concat,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation, retinal vein occlusion, interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, cuSCC, new primary melanoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, brain stem hemorrhage, cerebral hemorrhage, gastric hemorrhage, epistaxis, gingival hemorrhage, hematuria, vaginal hemorrhage, hemorrhage intracranial, eye hemorrhage, vitreous hemorrhage, renal failure, urinary tract infection, RPED, uveitis, iritis"
317,TANZEUM,all-concat,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, increased GGT, heart rate increase"
318,TECFIDERA,all-concat,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, Abdominal pain, Diarrhea, Nausea, Vomiting, Pruritus, Rash, Albumin urine present, Erythema, Dyspepsia, Aspartate aminotransferase increased, Eosinophilia"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
320,TIVICAY,all-concat,"Hypersensitivity reactions, Effects on serum liver biochemistries in patients with hepatitis B or C co-infection, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase, elevated total bilirubin, elevated lipase"
321,TOVIAZ,all-concat,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
322,TREANDA,all-concat,"Myelosuppression, Infections, Anaphylaxis and Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, Pyrexia, Nausea, Vomiting, Fatigue, Diarrhea, Constipation, Anorexia, Cough, Headache, Weight decreased, Dyspnea, Rash, Stomatitis, Lymphopenia, Anemia, Leukopenia, Thrombocytopenia, Neutropenia, Asthenia, Malaise, Weakness, Dry mouth, Somnolence, Mucosal inflammation, Worsening hypertension, Hypertensive crisis, Hypersensitivity, Nasopharyngitis, Infection, Herpes simplex, Hyperuricemia, Chills, Pruritus, Hemoglobin Decreased, Platelets Decreased, Leukocytes Decreased, Tachycardia, Constipation, Stomatitis, Abdominal pain, Dyspepsia, Gastroesophageal reflux disease, Abdominal pain upper, Abdominal distension, Edema peripheral, Chest pain, Infusion site pain, Pain, Catheter site pain, Herpes zoster, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Pneumonia, Febrile neutropenia, Oral candidiasis, Decreased appetite, Back pain, Arthralgia, Pain in extremity, Bone pain, Dizziness, Dysgeusia, Insomnia, Anxiety, Depression, Pharyngolaryngeal pain, Wheezing, Nasal congestion, Dry skin, Night sweats, Hyperhidrosis, Hypotension, Acute renal failure, Cardiac failure, Pulmonary fibrosis, Myelodysplastic syndrome, Hemolysis, Dysgeusia/taste disorder, Atypical pneumonia, Sepsis, Erythema, Dermatitis, Skin necrosis, Anaphylaxis, Injection or infusion site reactions including phlebitis, irritation, pain, and swelling, Pneumocystis jiroveci pneumonia, Pneumonitis, SJS, TEN"
323,TRULICITY,all-concat,"Risk of Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, systemic hypersensitivity reactions, injection-site reactions, PR Interval Prolongation, first degree Atrioventricular (AV) Block, amylase increase, lipase increase"
324,TUDORZA,all-concat,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, Headache, Nasopharyngitis, Cough, Diarrhea, Sinusitis, Rhinitis, Toothache, Fall, Vomiting, Diabetes mellitus, Dry mouth, 1st degree AV block, Osteoarthritis, Cardiac failure, Cardio-respiratory arrest, Anaphylaxis, Angioedema, Urticaria, Rash, Itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin and scalp symptoms, pain, pruritus, erythema, pyoderma, ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, gasping syndrome, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events"
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, anti-drug antibodies, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory illness, serious acute exacerbation of respiratory compromise, spinal or cervical cord compression, back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions"
330,VORAXAZE,all-concat,"Serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
331,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, Electrocardiogram QT prolonged, Eye Disorders, Gastrointestinal Disorders, General Disorders and Administration Site Conditions, Infections and Infestations, Investigations, Musculoskeletal and Connective Tissue Disorders, Nervous System Disorder, Headache, fatigue, neuropathy, rash, renal cyst, ILD, syncope, Neutropenia, Lymphopenia, Chemistry, ALT elevation, AST elevation, Hypophosphatemia, pneumonia, arrhythmia, acute respiratory distress syndrome, dyspnea, pneumonitis, respiratory failure, sepsis, Hypokalemia, hepatic failure, embryotoxicity, fetotoxicity"
332,XEOMIN,all-concat,"Hypersensitivity, Dysphagia, Breathing Difficulties, Spread of Effects from Toxin, Neck pain, Muscle weakness, Injection site pain, Musculoskeletal pain, Eyelid ptosis, Dry eye, Dry mouth, Diarrhea, Headache, Visual impairment, Dyspnea, Nasopharyngitis, Respiratory tract infection, Facial paresis, Injection site hematoma, Eyelid edema, Eye swelling, Nausea, Flu-like symptoms, Injection site reaction, Allergic dermatitis, Localized allergic reactions like swelling, Edema, Erythema, Pruritus or rash, Herpes zoster, Muscular weakness, Muscle spasm, Dysarthria, Myalgia, Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphonia, Urinary incontinence, Breathing difficulties, Corneal exposure, Corneal ulceration, Ectropion"
333,XIAFLEX,all-concat,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, flexor tendon rupture, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, blood blister, injection site hematoma, ecchymosis, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
334,XTANDI,all-concat,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections or sepsis resulting in death, fall-related injuries, hypertensive crisis"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, intestinal perforation, hepatotoxicity, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, Stevens-Johnson syndrome, toxic epidermal necrolysis, full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
336,ZERBAXA,all-concat,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, renal failure, dyspnea, urticaria, venous thrombosis"
337,ZYDELIG,all-concat,"Hepatotoxicity, Severe Diarrhea or Colitis, Pneumonitis, Intestinal Perforation, Severe Cutaneous Reactions, Anaphylaxis, Neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, neutropenia, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, pneumonia, pyrexia, sepsis, febrile neutropenia, elevated transaminases, nausea, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, GGT increased, triglycerides (hypertriglyceridemia), hypoglycemia, hyponatremia, diarrhea, abdominal pain, vomiting, fatigue, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, headache, decreased appetite, insomnia, ALT increased, AST increased, neutrophils decreased, hemoglobin decreased, platelets decreased"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, sinus bradycardia"
339,ZYTIGA,all-concat,"fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, hypokalemia, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, adrenocortical insufficiency, hepatotoxicity"
